Dermatomyositis and polymyositis in total hip arthroplasty

Table 2 Additional comorbidities for patients included in this study

Comorbidity	Proportion of IIM patients without comorbidity	Proportion of control patients without comorbidity	P value
AIDS	0.59%	1.74%	0.479
Congestive heart failure	29.66%	30.68%	1.000
Depression	37.3%	40.52%	0.402
Diabetes mellitus1	44.35%	58.61%	0.000
SUD–Drugs	6.31%	7.96%	0.910
SUD–Alcohol	2.35%	4.2%	0.716
Hypertension	89.43%	92.19%	0.112
Hypothyroidism	42.44%	38.21%	0.059
Liver disease	12.92%	12.45%	0.355
Lymphoma	3.38%	4.63%	1.000
Metastatic cancer	5.14%	6.8%	0.901
Neurological disease	13.07%	13.6%	0.742
Pulmonary disease1	45.96%	55.86%	0.001
PVD1	30.1%	30.54%	0.008

¹Denotes significance, P < 0.05. Reported percentages reflect the proportion of total patients in each of the two sample populations (e.g., patients with idiopathic inflammatory myopathies or controls) with the listed comorbidity. AIDS: Acquired immunodeficiency syndrome; SUD: Substance use disorder; PVD: Peripheral vascular disease; IIM: Idiopathic inflammatory myopathies.